Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Memorial Sloan Kettering Cancer Center

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1884-01-01

Employees: 10K

Market Cap: -

Website: http://www.mskcc.org

Clinical Trials

Combination Therapy With Entinostat and Pembrolizumab in Relapsed and Refractory Lymphomas

Phase 2

Active, not recruiting

Conditions: Lymphoma
Relapsed
Refractory

Interventions: Drug: Entinostat
Drug: Pembrolizumab

First Posted Date: 2017-06-07

Last Posted Date: 2025-01-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 47

Registration Number: NCT03179930

Locations: 🇺🇸
Roswell Park Cancer Institute (Data Collection Only), Buffalo, New York, United States
🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

and more 6 locations

Pembrolizumab and Involved Site Radiation Therapy for Early Stage Relapsed or Primary Refractory Hodgkin Lymphoma

Phase 2

Active, not recruiting

Conditions: Hodgkin Lymphoma

Interventions: Drug: Pembrolizumab
Radiation: Involved Site Radiation Therapy

First Posted Date: 2017-06-07

Last Posted Date: 2025-05-07

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 22

Registration Number: NCT03179917

Locations: 🇺🇸
University of Miami, Miami, Florida, United States
🇺🇸
Memorial Sloan Kettering at Basking Ridge, Basking Ridge, New Jersey, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 6 locations

Ambulatory Cancer Care Electronic Symptom Self-Reporting for Surgical Patients

Completed

Conditions: Patient Reported Outcomes

Interventions: Other: Team Monitoring
Other: Enhanced Feedback

First Posted Date: 2017-06-06

Last Posted Date: 2023-06-23

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 2793

Registration Number: NCT03178045

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Study of Nivolumab Plus Ipilimumab in Patients With Salivary Gland Cancer

Phase 2

Completed

Conditions: Salivary Gland Cancer

Interventions: Drug: Nivolumab
Drug: Ipilimumab

First Posted Date: 2017-06-01

Last Posted Date: 2024-12-24

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 64

Registration Number: NCT03172624

Locations: 🇺🇸
Memorial Sloan Kettering Commack, Commack, New York, United States
🇺🇸
Memorial Sloan Kettering Rockville Centre, Rockville Centre, New York, United States
🇺🇸
Memorial Sloan Kettering Monmouth, Middletown, New Jersey, United States

and more 5 locations

A Custom-Designed MR Coil for Spine Radiotherapy Treatment Planning

Completed

Conditions: Healthy

Interventions: Diagnostic Test: Custom Designed Spine Coil
Diagnostic Test: FDA approved spine coil

First Posted Date: 2017-05-31

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 8

Registration Number: NCT03170531

Locations: 🇺🇸
Memorial Sloan - Kettering Cancer Center, New York, New York, United States

Managing Anxiety From Cancer (MAC): Testing an Intervention for Anxiety in Older Adults With Cancer and Their Caregivers

Not Applicable

Active, not recruiting

Conditions: Anxiety
Depression
Quality of Life

Interventions: Behavioral: Managing Anxiety from Cancer (MAC)

First Posted Date: 2017-05-30

Last Posted Date: 2025-02-04

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 26

Registration Number: NCT03168971

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

PU-H71 With Nab-paclitaxel (Abraxane) in Metastatic Breast Cancer

Phase 1

Completed

Conditions: Metastatic Breast Cancer

Interventions: Drug: PU-H71
Drug: Nab-paclitaxel

First Posted Date: 2017-05-24

Last Posted Date: 2021-12-20

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 12

Registration Number: NCT03166085

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma

Phase 1

Completed

Conditions: Melanoma

Interventions: Drug: PF-06688992

First Posted Date: 2017-05-18

Last Posted Date: 2020-01-22

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 7

Registration Number: NCT03159117

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors

Phase 2

Active, not recruiting

Conditions: Nonseminomatous Germ Cell Tumor
Seminoma
Germinomatous Germ Cell Tumor
Dysgerminoma
Pineal Germ Cell Tumor
Germ Cell Tumor

Interventions: Drug: Durvalumab
Drug: Tremelimumab

First Posted Date: 2017-05-17

Last Posted Date: 2025-05-13

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 30

Registration Number: NCT03158064

Locations: 🇺🇸
Memorial Sloan Kettering Westchester, Harrison, New York, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Memorial Sloan Kettering Nassau, Uniondale, New York, United States

and more 4 locations

A Study of MEK162 (Binimetinib) in Combination With Pexidartinib in Patients With Advanced Gastrointestinal Stromal Tumor (GIST)

Phase 1

Completed

Conditions: Gastrointestinal Stromal Tumor (GIST)

Interventions: Drug: MEK162
Drug: Pexidartinib

First Posted Date: 2017-05-17

Last Posted Date: 2021-04-30

Lead Sponsor: Memorial Sloan Kettering Cancer Center

Target Recruit Count: 3

Registration Number: NCT03158103

Locations: 🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy